- Home
- / Hemostemix
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Hemostemix financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2024-10-29
Market Capitalization
$16.7 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 17, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | 2.0K | 200.0K | 1.6M | |||||
| Operating expense total | 6.4M | 3.0M | 3.3M | 1.1M | 2.3M | 1.9M | 2.0M | 5.7M |
| Depreciation and amortization | 2.0K | 2.0K | 1.0K | |||||
| EBITDA | (6.4M) | (3.0M) | (3.3M) | (1.1M) | (2.3M) | (1.7M) | (2.0M) | (4.1M) |
| EBIT | (6.4M) | (3.0M) | (3.3M) | (1.1M) | (2.3M) | (1.7M) | (2.0M) | (4.1M) |
| Interest income | 23.0K | |||||||
| Interest expense | 105.0K | 113.0K | 21.0K | 354.0K | 556.0K | 625.0K | 560.0K | |
| Pre tax profit | (6.2M) | (4.9M) | (7.8M) | (6.5M) | (4.7M) | (2.5M) | (2.6M) | (4.7M) |
| Income tax expense | (256.0K) | 487.0K | ||||||
| Net Income | (6.2M) | (4.9M) | (7.8M) | (6.3M) | (5.2M) | (2.5M) | (2.6M) | (4.7M) |